Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 1606 AL 1620

Utility of the Japanese version of the Clinical Dementia Rating® plus National Alzheimer's Coordinating Centre Behaviour and Language Domains for sporadic cases of frontotemporal dementia in Japan

Taomoto D, Sato S, Kanemoto H, Suzuki M, Hirakawa N, Takasaki A, Akimoto M, Satake Y, Koizumi F, Yoshiyama K, Takahashi R, Shigenobu K, Hashimoto M, Miyagawa T, Boeve B, Knopman D, Mori E, Ikeda M.

Psychogeriatrics. 2024 Mar;24(2):281-294. doi: 10.1111/psyg.13072. Epub 2023 Dec 28.

Alzheimer's disease and Alzheimer's disease-related dementias in Hispanics: Identifying influential factors and supporting caregivers

Rawat P, Sehar U, Bisht J, Reddy AP, Reddy PH.

Ageing Res Rev. 2024 Jan;93:102178. doi: 10.1016/j.arr.2023.102178. Epub 2023 Dec 27.

Effect and Potential Mechanism of Immunotherapy on Cognitive Deficits in Animal Models of Alzheimer's Disease: A Systematic Review and Meta-Analysis

Zhai Z, Kong F, Zhu Z, Dai J, Cai J, Xie D, Shen Y, Xu Y, Sun T.

Am J Geriatr Psychiatry. 2024 May;32(5):555-583. doi: 10.1016/j.jagp.2023.11.011. Epub 2023 Dec 7.

Umbrella review and Delphi study on modifiable factors for dementia risk reduction

Rosenau C, Köhler S, Soons LM, Anstey KJ, Brayne C, Brodaty H, Engedal K, Farina FR, Ganguli M, Livingston G, Lyketsos CG, Mangialasche F, Middleton LE, Rikkert MGMO, Peters R, Sachdev PS, Scarmeas N, Salbaek G, van Boxtel MPJ, Deckers K.

Alzheimers Dement. 2024 Mar;20(3):2223-2239. doi: 10.1002/alz.13577. Epub 2023 Dec 30.

Longitudinal Cognitive Decline in Alzheimer Disease Prevention Trials: A Test of Time

Castilhos RM, Snitz BE.

Neurology. 2024 Jan 23;102(2):e208067. doi: 10.1212/WNL.0000000000208067. Epub 2023 Dec 26.

Phase I trial of the MuSic to CONnect (MuSiCON) protocol: feasibility and effect of choir participation for individuals with cognitive impairment

Monroe P, Halaki M, Luscombe G, Kumfor F, Ballard KJ.

Brain Impair. 2023 Dec;24(3):732-749. doi: 10.1017/BrImp.2022.32. Epub 2023 Jan 6.

The Role of TNF-α in Alzheimer's Disease: A Narrative Review

Plantone D, Pardini M, Righi D, Manco C, Colombo BM, De Stefano N.

Cells. 2023 Dec 26;13(1):54. doi: 10.3390/cells13010054.

Recent advances in understanding of sleep disorders and disturbances for dementia risk and prevention

Lam A, Kong S, Naismith SL.

Curr Opin Psychiatry. 2024 Mar 1;37(2):94-100. doi: 10.1097/YCO.0000000000000921. Epub 2023 Dec 21.

Chitosan hydrogel nanoparticle enhance therapeutic effect of bovine umbilical mesenchymal stem cell conditioned medium on canine cognitive dysfunction or canine Alzheimer's like mediated by inhibition of neuronal apoptotic

Wihadmadyatami H, Zulfikar MA, Herawati H, Pratama DAOA, Saragih GR, Kustiati U, Handayani AN.

Open Vet J. 2023 Dec;13(12):1504-1516. doi: 10.5455/OVJ.2023.v13.i12.1. Epub 2023 Dec 31.

Orthostatic hypotension and cognitive impairment: Systematic review and meta-analysis of longitudinal studies

Duval GT, Raud E, Gohier H, Dramé M, Tabue-Teguo M, Annweiler C.

Maturitas. 2024 Jul;185:107866. doi: 10.1016/j.maturitas.2023.107866. Epub 2023 Nov 2.

Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals

Groot C, Smith R, Stomrud E, Binette AP, Leuzy A, Wuestefeld A, Wisse LEM, Palmqvist S, Mattsson-Carlgren N, Janelidze S, Strandberg O, Ossenkoppele R, Hansson O.

Brain. 2023 Apr 19;146(4):1580-1591. doi: 10.1093/brain/awac329.

Ocular Biomarkers for Alzheimer Disease Dementia: An Umbrella Review of Systematic Reviews and Meta-analyses

Costanzo E, Lengyel I, Parravano M, Biagini I, Veldsman M, Badhwar A, Betts M, Cherubini A, Llewellyn DJ, Lourida I, MacGillivray T, Rittman T, Tamburin S, Tai XY, Virgili G.

JAMA Ophthalmol. 2023 Jan 1;141(1):84-91. doi: 10.1001/jamaophthalmol.2022.4845.

Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography

Therriault J, Vermeiren M, Servaes S, Tissot C, Ashton NJ, Benedet AL, Karikari TK, Lantero-Rodriguez J, Brum WS, Lussier FZ, Bezgin G, Stevenson J, Rahmouni N, Kunach P, Wang YT, Fernandez-Arias J, Socualaya KQ, Macedo AC, Ferrari-Souza JP, Ferreira PCL, Bellaver B, Leffa DT, Zimmer ER, Vitali P, Soucy JP, Triana-Baltzer G, Kolb HC, Pascoal TA, Saha-Chaudhuri P, Gauthier S, Zetterberg H, Blennow K, Rosa-Neto P.

JAMA Neurol. 2023 Feb 1;80(2):188-199. doi: 10.1001/jamaneurol.2022.4485.

Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

Boerwinkle AH, Gordon BA, Wisch J, Flores S, Henson RL, Butt OH, McKay N, Chen CD, Benzinger TLS, Fagan AM, Handen BL, Christian BT, Head E, Mapstone M, Rafii MS, O'Bryant S, Lai F, Rosas HD, Lee JH, Silverman W, Brickman AM, Chhatwal JP, Cruchaga C, Perrin RJ, Xiong C, Hassenstab J, McDade E, Bateman RJ, Ances BM; Alzheimer's Biomarker Consortium-Down Syndrome; Dominantly Inherited Alzheimer Network.

Lancet Neurol. 2023 Jan;22(1):55-65. doi: 10.1016/S1474-4422(22)00408-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias